14th Jul 2010 14:40
Synergy Health PLC ("Synergy" or "the Company")
Synergy Health PLC has today been notified on 14 June 2010, certain Directors and persons discharging managerial responsibilities ("PDMR") of the Company, exercised options over Ordinary Shares of 0.625p each in the Company ("Ordinary Shares"). As part of the exercise of options and retention of shares under the Synergy Health Share Option Schemes as described below, LTIP Co-Invest options have been awarded to the following Directors/PDMRs.
|
Director/PDMR |
Exercise of options |
Number of shares sold |
Share price for shares sold (p) |
Shares retained and allocated to Co-Invest Scheme |
Co-Invest matching options exercised |
Shareholding post exercise/disposal |
Resultant shareholding (%) |
|
Paul Santing |
12,722 |
7,722 |
666.50 |
5,000 |
10,000 |
9,555 |
0.02 |
|
Marcello Smit |
15,669 |
6,681 |
666.50 |
8,988 |
17,976 |
31,988 |
0.06 |
|
Adrian Coward |
5,059 |
0 |
N/A |
5,059 |
10,118 |
5,059 |
0.01 |
Paul Santing and Marcello Smit exercised their options under the Synergy Health Long Term Incentive Plan and Adrian Coward exercised his under the Executive Share Option Scheme.
Dr. Richard Steeves, Chief Executive Officer of Synergy, has also notified the Company that he has allocated 43,445 Ordinary Shares to the LTIP Co-Invest scheme and as such has been awarded 86,890 LTIP Co-Invest options.
Gavin Hill, Finance Director of Synergy, has notified the Company that following the purchase of 7,900 Ordinary Shares at 675.00p and 900 Ordinary Shares at 674.00p, today, he has allocated these shares to the LTIP Co-Invest scheme. As such, Gavin Hill has been awarded 17,600 LTIP Co-Invest options. Following this purchase of shares, Gavin Hill has an interest in 16,300 Ordinary Shares, representing 0.03% of the Company's issued share capital.
The LTIP Co-Invest arrangement requires that the participant to whom the award is to be made invests in Ordinary Shares in the Company and continues to hold those Ordinary Shares throughout the three year measurement period. At the end of the measurement period, depending upon the growth in earnings per share of the Company over the measurement period, the participant will receive a number of "matching" shares at nominal value under the LTIP Co-Invest.
Enquiries
Tim Mason, Group Company Secretary +44 (0) 1793 891 862
Related Shares:
SYR.L